Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Medicamen Biotech Limited (NSE: MEDICAMEQ), ISIN INE646B01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MEDICAMEQ last traded at ₹323.90 (+1.38%), with a 52-week range of ₹210.10 to ₹454.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 40.46%, FIIs 0.07%, DIIs 0.40%, mutual funds 0.00%.
EquiSense Score (ECS): 63/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.